| Year |
Citation |
Score |
| 2023 |
Getu AA, Zhou M, Cheng SY, Tan M. The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy. Cancer Letters. 563: 216183. PMID 37094736 DOI: 10.1016/j.canlet.2023.216183 |
0.301 |
|
| 2022 |
Arora R, Kim JH, Getu AA, Angajala A, Chen YL, Wang B, Kahn AG, Chen H, Reshi L, Lu J, Zhang W, Zhou M, Tan M. MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer. Cells. 11. PMID 36552828 DOI: 10.3390/cells11244057 |
0.367 |
|
| 2020 |
Lynce F, Zhuo R, Blackburn M, Gallagher C, Hahn O, Abu-Khalaf M, Mohebtash M, Wu T, Pohlmann P, Dilawari A, Tiwari S, Chitalia A, Warren R, Tan M, Shajahan-Haq A, et al. Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P1-19-20 |
0.359 |
|
| 2019 |
Fernandez AI, Geng X, Chaldekas K, Harris B, Duttargi A, Berry VL, Berry DL, Mahajan A, Cavalli LR, Győrffy B, Tan M, Riggins RB. The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer. Breast Cancer Research and Treatment. PMID 31741180 DOI: 10.1007/S10549-019-05485-5 |
0.41 |
|
| 2019 |
Niu W, Luo Y, Wang X, Zhou Y, Li H, Wang H, Fu Y, Liu S, Yin S, Li J, Zhao R, Liu Y, Fan S, Li Z, Xiong W, ... ... Tan M, et al. Retraction Note: BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. Cell Death & Disease. 10: 640. PMID 31481653 DOI: 10.1038/S41419-019-1864-Y |
0.405 |
|
| 2019 |
Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802416RR. PMID 31408612 DOI: 10.1096/Fj.201802416Rr |
0.396 |
|
| 2019 |
Stone JK, Kim JH, Vukadin L, Richard A, Giannini HK, Lim SS, Tan M, Ahn EE. Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells. The Journal of Biological Chemistry. PMID 31167784 DOI: 10.1074/Jbc.Ra118.006889 |
0.429 |
|
| 2019 |
Clarke R, Tyson JJ, Tan M, Baumann WT, Jin L, Xuan J, Wang Y. Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers. Endocrine-Related Cancer. PMID 30965282 DOI: 10.1530/Erc-18-0309 |
0.377 |
|
| 2019 |
Zhou Y, Niu W, Luo Y, Li H, Xie Y, Wang H, Liu Y, Fan S, Li Z, Xiong W, Li X, Ren C, Tan M, Li G, Zhou M. The p53/LDHA axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53. Cancer Science. PMID 30618169 DOI: 10.1111/Cas.13928 |
0.429 |
|
| 2018 |
Liu Z, Zhang W, Phillips JB, Arora R, McClellan S, Li J, Kim JH, Sobol RW, Tan M. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation. Oncogene. PMID 30082909 DOI: 10.1038/S41388-018-0407-9 |
0.402 |
|
| 2018 |
Flem-Karlsen K, Fodstad Ø, Tan M, Nunes-Xavier CE. B7-H3 in Cancer - Beyond Immune Regulation. Trends in Cancer. 4: 401-404. PMID 29860983 DOI: 10.1016/J.Trecan.2018.03.010 |
0.324 |
|
| 2018 |
Niu W, Luo Y, Wang X, Zhou Y, Li H, Wang H, Fu Y, Liu S, Yin S, Li J, Zhao R, Liu Y, Fan S, Li Z, Xiong W, ... ... Tan M, et al. BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. Cell Death & Disease. 9: 519. PMID 29725006 DOI: 10.1038/S41419-018-0536-7 |
0.467 |
|
| 2018 |
Floros KV, Lochmann TL, Hu B, Monterrubio C, Hughes MT, Wells JD, Bernadó Morales C, Ghotra MS, Costa C, Souers AJ, Boikos SA, Leverson JD, Tan M, Serra V, Koblinski JE, et al. Coamplification ofprotects-amplified breast cancers from targeted therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 29476008 DOI: 10.1073/Pnas.1717820115 |
0.459 |
|
| 2018 |
Taylor H, Slamecka J, Musiyenko A, Gavin E, Norton TS, Aragon I, Young T, Scalici J, Rocconi RP, Tan M, Silva LMd. Abstract B31: Tumor-intrinsic B7-H3 regulates drug resistance, metabolism, and pathogenesis in ovarian cancer Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-B31 |
0.365 |
|
| 2018 |
Angajala A, Hughley R, Shweta T, Dean-Colomb W, Tan M, Yates C. Abstract A04: Identification of differentially expressed micro-RNAs in African American women with quadruple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-A04 |
0.349 |
|
| 2018 |
Stone JK, Kim J, Tan M, Ahn EE. Abstract 1479: Hypoxia upregulates the long noncoding RNA MALAT1 through increased chromatin looping Cancer Research. 78: 1479-1479. DOI: 10.1158/1538-7445.Am2018-1479 |
0.399 |
|
| 2018 |
Barac A, Lynce F, Medvedofsky DA, Geng X, Dang C, Yu A, Tan M, Isaacs C, Swain SM, Asch FM. P1578Global longitudinal strain in the SAFE-HEaRT study (Cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function) European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy565.P1578 |
0.326 |
|
| 2017 |
Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M, Li G, Zhou M. The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy. Oncotarget. 8: 57813-57825. PMID 28915713 DOI: 10.18632/Oncotarget.18175 |
0.378 |
|
| 2017 |
Luo Y, Wang X, Niu W, Wang H, Wen Q, Fan S, Zhao R, Li Z, Xiong W, Peng S, Zeng Z, Li X, Li G, Tan M, Zhou M. Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients. Oncology Letters. 13: 867-874. PMID 28356971 DOI: 10.3892/Ol.2016.5482 |
0.405 |
|
| 2017 |
Lim S, Phillips JB, Madeira da Silva L, Zhou M, Fodstad O, Owen LB, Tan M. Interplay between Immune Checkpoint Proteins and Cellular Metabolism. Cancer Research. PMID 28246276 DOI: 10.1158/0008-5472.Can-16-1647 |
0.31 |
|
| 2017 |
Shah N, Kelly W, Ma B, Puthiamadathil J, Serzan M, Zhou Y, Tan M, Subramaniam D, Giaccone G, Liu S. P2.07-050 Impact of Steroid Use for Immune Related Adverse Events on Outcomes in Non-Small Cell Lung Cancer (NSCLC) Treated with Checkpoint Inhibitors Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2017.09.1306 |
0.301 |
|
| 2016 |
Gao JJ, Tan M, Pohlmann PR, Swain SM. HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. Clinical Breast Cancer. PMID 27692565 DOI: 10.1016/J.Clbc.2016.08.005 |
0.382 |
|
| 2016 |
Nalbantoglu S, Abu-Asab M, Tan M, Zhang X, Cai L, Amri H. Study of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis. Omics : a Journal of Integrative Biology. 20: 442-447. PMID 27428255 DOI: 10.1089/Omi.2016.0059 |
0.301 |
|
| 2016 |
Lim S, Liu H, da Silva LM, Arora R, Liu Z, Phillips JB, Schmitt DC, Vu T, McClellan S, Lin Y, Lin W, Piazza GA, Fodstad O, Tan M. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α. Cancer Research. 76: 2231-2242. PMID 27197253 DOI: 10.1158/0008-5472.Can-15-1538 |
0.358 |
|
| 2016 |
Lim S, Smith KR, Lim ST, Tian R, Lu J, Tan M. Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation. Cell & Bioscience. 6: 25. PMID 27087918 DOI: 10.1186/S13578-016-0089-3 |
0.328 |
|
| 2016 |
Liu Y, Zhao R, Wang H, Luo Y, Wang X, Niu W, Zhou Y, Wen Q, Fan S, Li X, Xiong W, Ma J, Li X, Tan M, Li G, et al. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma. Cell Death & Disease. 7: e2156. PMID 27010857 DOI: 10.1038/Cddis.2016.64 |
0.321 |
|
| 2016 |
Tang X, Jin L, Cao P, Cao K, Huang C, Luo Y, Ma J, Shen S, Tan M, Li X, Zhou M. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression. Oncotarget. PMID 26993770 DOI: 10.18632/Oncotarget.8056 |
0.406 |
|
| 2016 |
Jin Y, Cai Q, Shenoy AK, Lim S, Zhang Y, Charles S, Tarrash M, Fu X, Kamarajugadda S, Trevino JG, Tan M, Lu J. Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation. Oncotarget. PMID 26848621 DOI: 10.18632/Oncotarget.7159 |
0.425 |
|
| 2016 |
Schmitt D, Andrews J, Tan M. Determination of Breast Cancer Cell Migratory Ability. Methods in Molecular Biology (Clifton, N.J.). 1406: 171-80. PMID 26820954 DOI: 10.1007/978-1-4939-3444-7_14 |
0.379 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Tan ML, ... ... Tan M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.335 |
|
| 2016 |
Nunes-Xavier CE, Karlsen KF, Tekle C, Pedersen C, Øyjord T, Hongisto V, Nesland JM, Tan M, Sahlberg KK, Fodstad Ø. Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors. Oncotarget. PMID 26771843 DOI: 10.18632/Oncotarget.6902 |
0.389 |
|
| 2016 |
Desai S, Tan M. Abstract B55: Role of HSF1 in chemotherapy-induced autophagy and endoplasmic reticulum stress response in breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-B55 |
0.406 |
|
| 2016 |
Dean-Colomb W, Tan M, Tang W, Ambs S, Yates C. Abstract P5-08-38: Low lactate dehydrogenase B expression correlates with decreased distant-metastasis free- and recurrence-free survival post-chemotherapy in basal-like breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-08-38 |
0.427 |
|
| 2016 |
Lim S, Liu H, Barnes L, Tan M. Abstract 48: The immunoregulatory protein B7-H3 regulates reprogramming of cancer cell glucose metabolism through reactive oxygen species mediated stabilization of HIF-1α Cancer Research. 76: 48-48. DOI: 10.1158/1538-7445.Am2016-48 |
0.348 |
|
| 2016 |
Nunes-Xavier CE, Karlsen KF, Øyjord T, Tan M, Fodstad Ø. Abstract 4133: Suppressed B7-H3 expression reduces glycolytic capacity and sensitizes tumor cells to anti-cancer agents Cancer Research. 76: 4133-4133. DOI: 10.1158/1538-7445.Am2016-4133 |
0.355 |
|
| 2016 |
Zou H, Ye N, Pang H, Zhang D, Yan R, Chen H, Cai G, Wang L, Yang Z, Chen H, Xu G, Zhang Y, Arora R, Tan M, Wei Y, et al. Abstract 329: Reprogramming glucose metabolism and energy production with a small molecule HJC0152 suppresses breast cancer development and progression to metastasis Cancer Research. 76: 329-329. DOI: 10.1158/1538-7445.Am2016-329 |
0.424 |
|
| 2016 |
Phillips J, Kim J, Lim S, Ahn E, Tan M. Abstract 1996: Regulation of RNA splicing of the ErbB family receptors by the splicing cofactor SON Cancer Research. 76: 1996-1996. DOI: 10.1158/1538-7445.Am2016-1996 |
0.442 |
|
| 2016 |
Stone JK, Kim J, Tan M, Ahn EE. Abstract 1835: NFATC1 regulates the long non-coding RNA MALAT1 in breast cancer Cancer Research. 76: 1835-1835. DOI: 10.1158/1538-7445.Am2016-1835 |
0.46 |
|
| 2015 |
Yuzefovych LV, Kahn AG, Schuler MA, Eide L, Arora R, Wilson GL, Tan M, Rachek LI. Mitochondrial DNA repair through OGG1 activity attenuates breast cancer progression and metastasis. Cancer Research. PMID 26586787 DOI: 10.1158/0008-5472.Can-15-0692 |
0.335 |
|
| 2015 |
Luo Y, Wang X, Wang H, Xu Y, Wen Q, Fan S, Zhao R, Jiang S, Yang J, Liu Y, Li X, Xiong W, Ma J, Peng S, Zeng Z, ... ... Tan M, et al. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel. Plos One. 10: e0138955. PMID 26406239 DOI: 10.1371/Journal.Pone.0138955 |
0.454 |
|
| 2015 |
Schmitt DC, Madeira da Silva L, Zhang W, Liu Z, Arora R, Lim S, Schuler AM, McClellan S, Andrews JF, Kahn AG, Zhou M, Ahn EY, Tan M. ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling. Cell Death & Disease. 6: e1742. PMID 25950472 DOI: 10.1038/Cddis.2015.116 |
0.329 |
|
| 2015 |
Arora R, Schmitt D, Karanam B, Tan M, Yates C, Dean-Colomb W. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers. Oncotarget. 6: 662-78. PMID 25575825 DOI: 10.18632/Oncotarget.2689 |
0.461 |
|
| 2015 |
Singh SR, Tan M, Rameshwar P. Cancer metabolism: targeting metabolic pathways in cancer therapy. Cancer Letters. 356: 147-8. PMID 24956174 DOI: 10.1016/J.Canlet.2014.06.002 |
0.322 |
|
| 2015 |
Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Letters. 356: 156-64. PMID 24732809 DOI: 10.1016/J.Canlet.2014.04.001 |
0.322 |
|
| 2014 |
Gong Z, Zhang S, Zeng Z, Wu H, Yang Q, Xiong F, Shi L, Yang J, Zhang W, Zhou Y, Zeng Y, Li X, Xiang B, Peng S, Zhou M, ... ... Tan M, et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. Plos One. 9: e110674. PMID 25422887 DOI: 10.1371/Journal.Pone.0110674 |
0.314 |
|
| 2014 |
Zhang W, Zeng Z, Wei F, Chen P, Schmitt DC, Fan S, Guo X, Liang F, Shi L, Liu Z, Zhang Z, Xiang B, Zhou M, Huang D, Tang K, ... ... Tan M, et al. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells. The Febs Journal. 281: 4815-29. PMID 25161098 DOI: 10.1111/Febs.13020 |
0.371 |
|
| 2014 |
Arora R, Yates C, Gary BD, McClellan S, Tan M, Xi Y, Reed E, Piazza GA, Owen LB, Dean-Colomb W. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer. Plos One. 9: e98370. PMID 24896091 DOI: 10.1371/Journal.Pone.0098370 |
0.443 |
|
| 2014 |
Bao T, Cai L, Snyder C, Betts K, Tarpinian K, Gould J, Jeter S, Medeiros M, Chumsri S, Bardia A, Tan M, Singh H, Tkaczuk KH, Stearns V. Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms. Cancer. 120: 381-9. PMID 24375332 DOI: 10.1002/Cncr.28352 |
0.33 |
|
| 2014 |
Desai S, Ding M, Wang B, Lu Z, Zhao Q, Shaw K, Yung WK, Weinstein JN, Tan M, Yao J. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. Oncotarget. 5: 8202-10. PMID 24077665 DOI: 10.18632/Oncotarget.1159 |
0.38 |
|
| 2014 |
Arora R, Schmitt D, McClellan S, Tan M, Dean-Colomb W. Abstract 3370: Natural compound targeting metabolism: A new insight for the treatment of triple negative breast cancer Cancer Research. 74: 3370-3370. DOI: 10.1158/1538-7445.Am2014-3370 |
0.433 |
|
| 2013 |
Butler EB, Zhao Y, Muñoz-Pinedo C, Lu J, Tan M. Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Research. 73: 2709-17. PMID 23610447 DOI: 10.1158/0008-5472.Can-12-3009 |
0.358 |
|
| 2013 |
Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death & Disease. 4: e532. PMID 23470539 DOI: 10.1038/Cddis.2013.60 |
0.358 |
|
| 2013 |
Kamarajugadda S, Cai Q, Chen H, Nayak S, Zhu J, He M, Jin Y, Zhang Y, Ai L, Martin SS, Tan M, Lu J. Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis. Cell Death & Disease. 4: e504. PMID 23429290 DOI: 10.1038/Cddis.2013.20 |
0.373 |
|
| 2013 |
Desai S, Liu Z, Yao J, Patel N, Chen J, Wu Y, Ahn EE, Fodstad O, Tan M. Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7). The Journal of Biological Chemistry. 288: 9165-76. PMID 23386620 DOI: 10.1074/Jbc.M112.422071 |
0.401 |
|
| 2013 |
Liu Z, Liu H, Desai S, Schmitt DC, Zhou M, Khong HT, Klos KS, McClellan S, Fodstad O, Tan M. miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. The Journal of Biological Chemistry. 288: 4334-45. PMID 23255607 DOI: 10.1074/Jbc.M112.419168 |
0.746 |
|
| 2013 |
Arora R, Schmitt D, McClellan S, Tan M, Reed E, Owen L, Dean-Colomb WM. Reversal of the Warburg effect in breast cancer cells by a novel agent. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E13566 |
0.413 |
|
| 2013 |
Liu Z, Liu H, Desai S, Schmitt DC, Zhou M, Khong HT, Klos KS, McClellan S, Fodstad O, Tan M. Abstract LB-242: MicroRNA-125b, a key mediator for Snail-induced stem cell propagation and chemoresistance. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-242 |
0.356 |
|
| 2013 |
Ding Y, Liu Z, Desai S, Pannell L, Yi H, Wright E, Owen L, Dean-Colomb W, Fodstad O, Lu J, Tan M. Abstract 3025: Receptor tyrosine kinase ErbB2/HER2 translocates into mitochondria and regulates cellular metabolism. Cancer Research. 73: 3025-3025. DOI: 10.1158/1538-7445.Am2013-3025 |
0.381 |
|
| 2013 |
Arora R, Tan M, Yates C, Dean-Colomb W. Abstract P1-07-07: Targeting reversal of epithelial-mesenchymal transition through FOXM1 inhibition in breast cancer cells Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-07-07 |
0.474 |
|
| 2013 |
Lynce F, Barac A, Tan M, Nunes R, Herbolsheimer P, Isaacs C, Swain S. Abstract OT1-1-12: SAFE-HEaRt: A pilot study assessing the cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Ot1-1-12 |
0.324 |
|
| 2012 |
Ding Y, Liu Z, Desai S, Zhao Y, Liu H, Pannell LK, Yi H, Wright ER, Owen LB, Dean-Colomb W, Fodstad O, Lu J, Ledoux SP, Wilson GL, Tan M. Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism Nature Communications. 3. PMID 23232401 DOI: 10.1038/Ncomms2236 |
0.355 |
|
| 2012 |
Tan M, Yu D, Jin Y, Dou L, Li B, Wang Y, Yue J, Liang L. An information transmission model for transcription factor binding at regulatory DNA sites. Theoretical Biology & Medical Modelling. 9: 19. PMID 22672438 DOI: 10.1186/1742-4682-9-19 |
0.434 |
|
| 2012 |
Kamarajugadda S, Stemboroski L, Cai Q, Simpson NE, Nayak S, Tan M, Lu J. Glucose oxidation modulates anoikis and tumor metastasis Molecular and Cellular Biology. 32: 1893-1907. PMID 22431524 DOI: 10.1128/Mcb.06248-11 |
0.345 |
|
| 2012 |
Desai S, Liu Z, Fodstad O, Tan M. Abstract LB-488: Induction of autophagy by heat shock factor 1 promotes breast cancer resistance to chemotherapy Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-488 |
0.455 |
|
| 2012 |
Zhao Y, Zhou M, LeDoux S, Wilson G, Yu D, Price J, Fodstad O, Tan M. Abstract 3208: Overcoming cancer therapeutic resistance by targeting dysregulated glucose metabolism Cancer Research. 72: 3208-3208. DOI: 10.1158/1538-7445.Am2012-3208 |
0.652 |
|
| 2012 |
Tekle C, Nygren MK, Pedersen C, Ingebrigtsen VA, Kleivi KS, Tan M, Fodstad O. Abstract 1863: The multifunconal role of B7-H3 in metastasis and drug resistance Cancer Research. 72: 1863-1863. DOI: 10.1158/1538-7445.Am2012-1863 |
0.364 |
|
| 2011 |
Tan BZ, Jiang F, Tan MY, Yu D, Huang H, Shen Y, Soong TW. Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels. The Journal of Biological Chemistry. 286: 42725-35. PMID 21998309 DOI: 10.1074/jbc.M111.265207 |
0.423 |
|
| 2011 |
Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, Nesland JM, Fodstad O, Tan M. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Molecular Cancer Therapeutics. 10: 960-71. PMID 21518725 DOI: 10.1158/1535-7163.Mct-11-0072 |
0.383 |
|
| 2011 |
Zhao Y, Liu H, Liu Z, Ding Y, Ledoux SP, Wilson GL, Voellmy R, Lin Y, Lin W, Nahta R, Liu B, Fodstad O, Chen J, Wu Y, Price JE, ... Tan M, et al. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Research. 71: 4585-97. PMID 21498634 DOI: 10.1158/0008-5472.Can-11-0127 |
0.454 |
|
| 2011 |
Zhao Y, Liu H, Riker AI, Fodstad O, Ledoux SP, Wilson GL, Tan M. Emerging metabolic targets in cancer therapy Frontiers in Bioscience. 16: 1844-1860. PMID 21196269 DOI: 10.2741/3826 |
0.388 |
|
| 2011 |
Liu Z, Zhou M, Zhao Y, Yan D, Liu H, Tan M. Abstract 2130: Overcoming chemotherapy resistance by targeting LDHA mediated glycolysis Cancer Research. 71: 2130-2130. DOI: 10.1158/1538-7445.Am2011-2130 |
0.438 |
|
| 2011 |
Bao T, Tarpinian K, Medeiros M, Gould J, Jeter S, Cai L, Tait N, Shetty J, Lewis J, Gitten L, Betts K, Hoffman A, Feigenberg S, Chumsri S, Armstronge D, ... ... Tan M, et al. P4-12-13: A Multi-Center Randomized Controlled Double Blind Trial Assessing the Effect of Acupuncture in Reducing Musculoskeletal Symptoms in Breast Cancer Patients Taking Aromatase Inhibitors: First Interim Analysis. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-12-13 |
0.344 |
|
| 2010 |
Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. The Journal of Biological Chemistry. 285: 21496-507. PMID 20460378 DOI: 10.1074/Jbc.M109.083337 |
0.332 |
|
| 2010 |
Matrone MA, Whipple RA, Thompson K, Cho EH, Vitolo MI, Balzer EM, Yoon JR, Ioffe OB, Tuttle KC, Tan M, Martin SS. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene. 29: 3217-27. PMID 20228842 DOI: 10.1038/Onc.2010.68 |
0.39 |
|
| 2010 |
Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, Riker AI, Kamarajugadda S, Lu J, Owen LB, Ledoux SP, Tan M. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Molecular Cancer. 9: 33. PMID 20144215 DOI: 10.1186/1476-4598-9-33 |
0.322 |
|
| 2010 |
Mehnert JM, Hausner PF, Tan M, Weber D, Sausville EA. Treatment of melanoma with wild-type p53 (wtp53) and detectable S100B using pentamidine: A phase II trial with correlative biomarker endpoints. Journal of Clinical Oncology. 28: TPS310-TPS310. DOI: 10.1200/Jco.2010.28.15_Suppl.Tps310 |
0.373 |
|
| 2010 |
Tekle C, Liu H, Chen Y, Mælandsmo GM, Fodstad O, Tan M. Abstract 2550: B7-H3 induces paclitaxel resistance in human breast cancer cell lines Cancer Research. 70: 2550-2550. DOI: 10.1158/1538-7445.Am10-2550 |
0.427 |
|
| 2010 |
Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M. Abstract 2109: Mir-125b confers the resistance of cancer cells to Taxol through suppression of Bak1 Cancer Research. 70: 2109-2109. DOI: 10.1158/1538-7445.Am10-2109 |
0.377 |
|
| 2009 |
Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene. 28: 3689-701. PMID 19668225 DOI: 10.1038/Onc.2009.229 |
0.647 |
|
| 2009 |
Lu J, Tan M, Huang WC, Li P, Guo H, Tseng LM, Su XH, Yang WT, Treekitkarnmongkol W, Andreeff M, Symmans F, Yu D. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1326-34. PMID 19228734 DOI: 10.1158/1078-0432.Ccr-08-0954 |
0.631 |
|
| 2009 |
Tkaczuk K, Tait N, Ioffe O, Rogers W, Tan M, Lesko S, Lum Z, Deamond S, Shan E, Daniel J, VanEcho D, Ts'o P. A retrospective study of drug response indicator test (DRIT) as a predictive test for therapeutic treatment outcomes of advanced breast cancer patients (ABC). Cancer Research. 69: 6075. DOI: 10.1158/0008-5472.Sabcs-6075 |
0.301 |
|
| 2008 |
Tkaczuk KH, Goloubeva O, Tait NS, Feldman F, Tan M, Lum ZP, Lesko SA, Van Echo DA, Ts'o PO. The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method. Breast Cancer Research and Treatment. 111: 355-64. PMID 18064568 DOI: 10.1007/S10549-007-9771-9 |
0.408 |
|
| 2007 |
Tan M, Yu D. Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Advances in Experimental Medicine and Biology. 608: 119-29. PMID 17993237 DOI: 10.1007/978-0-387-74039-3_9 |
0.549 |
|
| 2006 |
Tan M, Lan KH, Yao J, Lu CH, Sun M, Neal CL, Lu J, Yu D. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. Cancer Research. 66: 3764-72. PMID 16585203 DOI: 10.1158/0008-5472.Can-05-2747 |
0.779 |
|
| 2006 |
Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Research. 66: 2028-37. PMID 16489002 DOI: 10.1158/0008-5472.Can-04-4559 |
0.798 |
|
| 2006 |
Tan M, Li P, Sun M, Yin G, Yu D. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene. 25: 3286-95. PMID 16407820 DOI: 10.1038/Sj.Onc.1209361 |
0.67 |
|
| 2005 |
Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y, Fang D, Jing T, Yu D. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis. Cancer Research. 65: 1858-67. PMID 15753384 DOI: 10.1158/0008-5472.Can-04-2353 |
0.773 |
|
| 2004 |
Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D, Hung MC. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell. 6: 459-69. PMID 15542430 DOI: 10.1016/J.Ccr.2004.09.027 |
0.686 |
|
| 2004 |
Zhou X, Tan M, Stone Hawthorne V, Klos KS, Lan KH, Yang Y, Yang W, Smith TL, Shi D, Yu D. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6779-88. PMID 15501954 DOI: 10.1158/1078-0432.Ccr-04-0112 |
0.793 |
|
| 2004 |
Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell. 6: 117-27. PMID 15324695 DOI: 10.1016/J.Ccr.2004.06.022 |
0.782 |
|
| 2002 |
Tan M, Fang H, Tian G, Houghton PJ. Small-sample inference for incomplete longitudinal data with truncation and censoring in tumor xenograft models. Biometrics. 58: 612-620. PMID 12229996 DOI: 10.1111/J.0006-341X.2002.00612.X |
0.324 |
|
| 2002 |
Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S, Fang D, Nagata Y, Liu J, Arlinghaus R, Hung MC, Yu D. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Molecular Cell. 9: 993-1004. PMID 12049736 DOI: 10.1016/S1097-2765(02)00510-5 |
0.774 |
|
| 1999 |
Tan M, Grijalva R, Yu D. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase. Cancer Research. 59: 1620-5. PMID 10197638 |
0.791 |
|
| 1998 |
Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell TJ, Hung MC. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Molecular Cell. 2: 581-91. PMID 9844631 DOI: 10.1016/S1097-2765(00)80157-4 |
0.797 |
|
| 1998 |
Pollock R, Lang A, Ge T, Sun D, Tan M, Yu D. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 1985-94. PMID 9717829 |
0.507 |
|
| 1998 |
Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 1065-70. PMID 9563903 |
0.522 |
|
| 1997 |
Tan M, Yao J, Yu D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Research. 57: 1199-205. PMID 9067293 |
0.588 |
|
| 1996 |
Yu D, Liu B, Tan M, Li J, Wang SS, Hung MC. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene. 13: 1359-65. PMID 8808711 |
0.578 |
|
| Show low-probability matches. |